Prosthetic Heart Valves Market, by Product Type (Mechanical Heart Valves (Mechanical Aortic Valve and Mechanical Mitral Valve), Biological/Tissue Heart Valves (Tissue Aortic Valve and Tissue Mitral Valve), and Transcatheter Heart Valves (Transcatheter Aor

Prosthetic Heart Valves Market, by Product Type (Mechanical Heart Valves (Mechanical Aortic Valve and Mechanical Mitral Valve), Biological/Tissue Heart Valves (Tissue Aortic Valve and Tissue Mitral Valve), and Transcatheter Heart Valves (Transcatheter Aortic Valve and Transcatheter Mitral Valve)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Mechanical heart valve is an artificial heart valve implanted in a patient suffering from diseases such as aortic stenosis or mitral regurgitation. There are two types of mechanical heart valves: mechanical aortic valve and mechanical mitral valve. Mechanical heart valve is the most widely used prosthetic heart valve for the treatment of patients suffering from valvular heart disease. The increasing number of heart valve implantation procedures is expected to propel the growth of the global prosthetic heart valves market over the forecast period. Moreover, growing healthcare expenditure and the increasing number of mitral valve replacements among the population suffering from valvular heart diseases are anticipated to assist the market growth during the forecasted period.

Market Dynamics

Technological advancements in prosthetic heart valves, an increase in the prevalence of HVD (Heart Valve Disease), regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenarios for prosthetic heart valves are expected to drive the growth of the market. Moreover, the rising geriatric population and sedentary lifestyle is also expected to provide lucrative growth to global prosthetic heart valves market. For instance, according to the WHO (World Health Organization) as on October 4, 2021, there were around 1.4 billion people above the age of 60 in 2020. This number is expected to be doubled by 2050 (2.1 billion). The pace of population aging is much faster than in the past, thus, it is expected to drive the global prosthetic heart valves market growth over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global prosthetic heart valves market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prosthetic heart valves market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prosthetic heart valves market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valves market
Detailed Segmentation:
  • Global Prosthetic Heart Valves Market, By Product Type:
  • Mechanical Heart Valves
  • Mechanical Aortic Valve
  • Mechanical Mitral Valve
  • Biological/Tissue Heart Valves
  • Tissue Aortic Valve
  • Tissue Mitral Valve
  • Transcatheter Heart Valves
  • Transcatheter Aortic Valve
  • Transcatheter Mitral Valve
  • Global Prosthetic Heart Valves Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Global Prosthetic Heart Valves Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Edwards Lifesciences Corporation *
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife, Inc.
  • Braile Biomedica
  • Colibri Heart Valve, LLC
  • JenaValve Technology, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By End User  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Key highlights o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Regulatory Scenario o PEST Analysis 4. Global Prosthetic Heart Valves Market- Impact of Coronavirus (Covid-19) Pandemic o Overall Impact o Impact on Supply and Demand o COVID-19 Impact on the market 5. Global Prosthetic Heart Valves Market, By Product Type, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Mechanical Heart Valves  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Mechanical Aortic Valve o Mechanical Mitral Valve o Biological/Tissue Heart Valves  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Tissue Aortic Valve o Tissue Mitral Valve o Transcatheter Heart Valves  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Transcatheter Aortic Valve o Transcatheter Mitral Valve 6. Global Prosthetic Heart Valves Market, By End User, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Hospitals  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Ambulaqtory Surgical Centers  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 7. Global Prosthetic Heart Valves Market, By Region, 2017 – 2030, (US$ Million) o Introduction  Market Share Analysis, By Region, 2022 and 2030 (%)  Y-o-Y Growth Analysis, For Regions, 2017–2030  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Edwards Lifesciences Corporation  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Medtronic plc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Boston Scientific Corporation  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o LivaNova PLC  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o CryoLife, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Braile Biomedica  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Colibri Heart Valve, LLC  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o JenaValve Technology, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us *Browse 27 market data tables and 26 figures on "Global Prosthetic Heart Valves Market” - Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings